EM2P2
EM2P2 is a Cleveland-based software company operating the HIPAA-compliant CannaLnx SaaS platform, which connects physicians, patients, dispensaries, growers, and third-party administrators to automate medical cannabis recommendations and enable insurance reimbursement up to $175 per month through employer health plans.
- Company typePrivate
- Founded2018
- HeadquartersCleveland, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What EM2P2 does
EM2P2, Inc. is a Cleveland, Ohio-based, founder-led private software company (founded 2018, 11–50 employees) that has built and commercialized the CannaLnx platform — a cloud-based, HIPAA-compliant, patent-pending SaaS registry and transaction-processing tool serving the medical cannabis industry. The platform connects recommending physicians, patients, dispensaries, growers, processors, and test labs, automating recommendation issuance, dispensary fulfillment verification, and ongoing tracking. Its core technical differentiator is end-to-end connectivity without requiring new POS systems or specialized hardware, with bilingual (Spanish/English) interface support.
The company's central commercial proposition is integrating insurance reimbursement into medical cannabis. Eligible patients can receive $100–$175 per month in reimbursements for qualified cannabis purchases and doctor visits through employer health plans and wellness benefits programs, processed via third-party administrator (TPA) partners including Detego Health, 90 Degrees, and Iron Health. Revenue is generated primarily through SaaS platform subscriptions (quote-based, monthly billing) supplemented by transaction-linked economics from the reimbursement flow. Distribution combines direct enterprise sales, TPA channels into employer plans, dispensary and delivery partner networks, and association-led outreach via the American Society of Cannabis Medicine (ASCM), the American Council of Cannabis Medicine (ACCM — for which EM2P2 is the exclusive tech partner), CannaScripts, and the Coalition for Medical Cannabis.
EM2P2's commercial footprint is currently anchored in California (Los Angeles, Bay Area, Sacramento — 9 dispensary/delivery operators, 15 storefronts) with stated intent for national rollout. The company is operating, actively publishing press in 2025–2026, and has no disclosed institutional funding, parent company, or M&A activity in the source material; ownership and capital structure remain opaque.
EM2P2 firmographics
Firmographics- Name
- EM2P2
- Legal name
- EM2P2, Inc.
- Website
- https://em2p2.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- EM2P2 is a Cleveland-based software company operating the HIPAA-compliant CannaLnx SaaS platform, which connects physicians, patients, dispensaries, growers, and third-party administrators to automate medical cannabis recommendations and enable insurance reimbursement up to $175 per month through employer health plans.
- Ownership category
- akta.pro rank
EM2P2 industry classification
Industry- Product category
- Medical Cannabis Healthcare Software
- NAICS
- Direct Health and Medical Insurance Carriers (524114), Health and Welfare Funds (525120), Insurance and Employee Benefit Funds (5251)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Insurance Agents, Brokers & Service (6411), Hospital & Medical Service Plans (6324)
- akta.pro primary industry
- Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services) (CRANAFAI)
- akta.pro secondary industries
- Medication Pricing, Copay Assistance & Patient Financial Support Tools (HLACAKAN), Prior Authorization (ePA), Utilization Management & Coverage Verification (HLACAKAE)
Keywords
Where EM2P2 is headquartered
LocationHeadquarters
- HQ city
- Cleveland
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
EM2P2 business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- SaaS Platform Subscriptions: EM2P2 offers an online subscription to the CannaLnx SaaS platform for medical cannabis industry participants including doctors, patients, dispensaries, growers, test labs, and state program administrators. The platform connects patients, third-party administrators, and licensed insurance brokers.
- Insurance Reimbursement Facilitation: The platform enables eligible patients to receive monthly reimbursements of $100 to $175 for medical cannabis and related doctor visits through employer health plans and wellness benefits programs.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Platform subscription with insurance reimbursement integration |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels5 records
EM2P2 product offering
Product offeringCore offering
EM2P2 develops and delivers the CannaLnx platform, a cloud-based HIPAA-compliant SaaS registry and tracking tool that automates, processes, monitors, and reports on medical cannabis recommendations and dispensary fulfillment. It connects recommending physicians, patients, dispensaries, growers, processors, and test labs, and integrates with third-party administrators (Detego Health, 90 Degrees, Iron Health) to facilitate insurance reimbursements of $100–$175 per month through employer health plans.
Product overview
EM2P2 operates as a single-product company offering the CannaLnx platform — a cloud-based HIPAA-compliant SaaS solution that serves as the central hub for medical cannabis recommendation processing, dispensary fulfillment tracking, and insurance-integrated reimbursement facilitation. The platform connects recommending physicians, patients, dispensaries, growers, test labs, and third-party administrators to enable a streamlined workflow from certification through reimbursement, positioning itself as the first fully compliant bridge between healthcare and cannabis.
Differentiator
Problem solved
Functional benefit
Brands
- Elevated States Program: A program under the American Council of Cannabis Medicine that offers reimbursements up to $175 per month for medical cannabis purchases and doctor visits, facilitated through EM2P2's CannaLnx platform.
Products and services
- CannaLnx Platform A cloud-based HIPAA-compliant SaaS registry, tracking, and transaction-processing platform for the medical cannabis industry. Connects recommending physicians, patients, dispensaries, growers, processors, and test labs, and integrates with third-party administrators (Detego Health, 90 Degrees, Iron Health) to facilitate insurance reimbursements of $100–$175 per month to eligible patients through employer health plans.
Quantifiable outcome
- Patients can receive up to $175 per month in reimbursements for medical cannabis purchases through employer health plans
Companies that use EM2P2
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles4 records
EM2P2 technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
Feature4 records
EM2P2 partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core and minor.
- Nine California Dispensary and Delivery OperatorscoreNine dispensary and delivery operators representing 15 storefronts across Los Angeles, the Bay Area, and Sacramento participate in CannaLnx's insurance reimbursement program, marking one of the most significant real-world implementations of insurance-integrated medical cannabis infrastructure.
- National Health Care Sharing AssociationcoreACCM joined the National Health Care Sharing Association's Building Bridges Program to help their members participate in medical cannabis reimbursement programs through CannaLnx.
- Detego HealthcoreThird-party administrator (TPA) and early partner of CannaLnx, enabling insurance reimbursement processing for medical cannabis through employer health plans.
- 90 DegreescoreThird-party administrator (TPA) and early partner of CannaLnx platform, facilitating insurance integration for medical cannabis reimbursements.
- Iron HealthcoreThird-party administrator (TPA) and early partner enabling insurance processing for medical cannabis reimbursement on the CannaLnx platform.
- American Society of Cannabis Medicine (ASCM)coreASCM officially recommends CannaLnx as the standard for use by its member physicians. EM2P2 and ASCM focus specifically on the medical cannabis market using unique tools and relationships.
- American Council of Cannabis Medicine (ACCM)coreWashington DC-based nonprofit dedicated to medical-cannabis advocacy. ACCM is the exclusive tech partner for EM2P2. ACCM announced national initiatives to expand medical cannabis access through partnerships with insurers, health systems, and wellness organizations.
- CannaScriptscoreCannaScripts provides medical-cannabis group-saving and physician/patient education programs. Together with EM2P2 and ASCM, they form an ecosystem targeting the medical cannabis market.
- Coalition for Medical Cannabis (CMC)minorWashington DC-based nonprofit dedicated to medical-cannabis advocacy, partnering with EM2P2 to advance medical cannabis solutions.
Scale indicators3 records
Recent moves7 records
Expansion highlights6 records
EM2P2 competitors and assessment
Company assessmentEmerging players
- CanPay: CanPay is a cannabis-friendly payments network and debit solution for dispensaries. Comparable as infrastructure addressing pain points at the dispensary transaction layer; adjacent rather than overlapping with CannaLnx's recommendation and reimbursement workflows.
- Meadow: Meadow is a cannabis dispensary and delivery management platform with POS, e-commerce, and compliance features. Comparable as a regional dispensary SaaS player in California; narrower footprint than CannaLnx's multi-stakeholder model.
Direct peers
- Flowhub: Flowhub is a cannabis dispensary management and compliance platform covering POS, inventory, and seed-to-sale tracking. Comparable as a dispensary-facing SaaS in the same regulatory niche; differs in lacking CannaLnx's physician-side certification and insurance integration.
- Dutchie: Dutchie is a leading cannabis e-commerce and POS SaaS platform serving dispensaries. Highly comparable as a horizontal SaaS layer between dispensaries and patients; differs in that Dutchie has not built insurance reimbursement rails like CannaLnx.
- iHeartJane / Jane Technologies: iHeartJane is an e-commerce and menu platform for cannabis dispensaries with patient-facing ordering. Comparable as a dispensary-patient SaaS; comparable HIPAA-aware stack but not focused on insurance reimbursement workflows.
- SpringBig: SpringBig provides CRM, loyalty, and marketing automation for cannabis dispensaries. Comparable SaaS sold into the same dispensary buyer; differs as a marketing-focused vertical rather than certification/reimbursement infrastructure.
- Cova Software: Cova is a cannabis dispensary POS and inventory platform. Comparable as a dispensary point-of-sale SaaS competing for the same dispensary IT budget; lacks the physician-recommendation and reimbursement layer CannaLnx provides.
Broad incumbents
- Leafly Holdings: Leafly is a cannabis information, e-commerce, and media platform serving consumers and retailers. Comparable audience (patients and dispensaries); broader content-driven model without integrated reimbursement.
- BioTrackTHC (Akerna / Cencora): BioTrackTHC, now part of Akerna, provides seed-to-sale tracking and compliance software for cannabis operators and regulators. Comparable as a compliance-grade cannabis software incumbent; operates more broadly across the supply chain rather than at the patient/reimbursement interface.
- Weedmaps: Weedmaps is a large cannabis marketplace connecting consumers with dispensaries and brands. Comparable as a horizontal cannabis platform reaching the same patient segment; broader consumer-facing model without physician certification or insurance rails.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
EM2P2 social profiles
Digital presenceEM2P2 compliance and trust
Trust signalCompliance1 record
EM2P2 financial estimates
Financial estimateRevenue estimate
Valuation estimate
EM2P2 leadership team
Management profileNumber of profiles
Profiles6 records
EM2P2 funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
EM2P2 M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about EM2P2
What does EM2P2 do?
EM2P2 develops and delivers the CannaLnx platform, a cloud-based HIPAA-compliant SaaS registry and tracking tool that automates, processes, monitors, and reports on medical cannabis recommendations and dispensary fulfillment. It connects recommending physicians, patients, dispensaries, growers, processors, and test labs, and integrates with third-party administrators (Detego Health, 90 Degrees, Iron Health) to facilitate insurance reimbursements of $100–$175 per month through employer health plans.
Is EM2P2 a public or private company?
EM2P2 is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was EM2P2 founded?
EM2P2 was founded in 2018. It employs 11 to 50 people.
Where is EM2P2 based?
EM2P2 is headquartered in Cleveland, United States, in the North America region.
How does EM2P2 make money?
Two revenue lines are on record. SaaS Platform Subscriptions are the primary driver. The others are insurance Reimbursement Facilitation.
Who are EM2P2's main competitors?
Emerging players on record are CanPay and Meadow. Direct peers are Flowhub, Dutchie, iHeartJane / Jane Technologies, SpringBig and Cova Software. Broad incumbents are Leafly Holdings, BioTrackTHC (Akerna / Cencora) and Weedmaps.
Does EM2P2 have an API?
No public API is recorded for EM2P2.
What industry is EM2P2 in?
EM2P2's product category is Medical Cannabis Healthcare Software. Its primary akta.pro industry code is CRANAFAI, Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services), with a secondary code of HLACAKAN, Medication Pricing, Copay Assistance & Patient Financial Support Tools. Its NAICS code is 524114 and its SIC code is 8011.